Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ·Healthcare·Biotechnology
$7.45
-2.87%
Mkt Cap $1.46B
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$8.82
Range $4.00 – $18.00
Implied Upside
+18.4%
Consensus $8.82 vs current $7.45
NASDAQ·Healthcare·Biotechnology
$7.45
-2.87%
Mkt Cap $1.46B
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$8.82
Range $4.00 – $18.00
+18.4%
Consensus $8.82 vs current $7.45